Watch Demo

Nectar Lifesciences Ltd. (India)

Nectar Lifesciences Ltd. (India)

  • Publish Date:March 2016

  • Number of Pages:89

  • Report ID:3906939

  • Format:PDF

  • Publisher:Global Industry Analysts

$ 3500

Summary

This report presents quick facts about Nectar Lifesciences Ltd., which is principally involved in Pharmaceuticals Business. Illustrated with 85 tables, the report showcases the company's sales performance, key markets and market position as against its competitors operating in the industry.

Table of contents



1. COMPANY SNIPPETS.............. 1

2. MAJOR PRODUCTS AND SERVICES..............2

3. SALES DATA.............. 5 Table 1: Nectar Lifesciences Ltd.'s (Operations) Sales by Geographic Region Worldwide (2014-2015) in Percentage for India and Others.............. 5

4. MARKET OVERVIEW.............. 6 Active Pharmaceutical Ingredients (API) 6 Table 2: Active Pharmaceutical Ingredients (API) Manufacturers Market by Segment Worldwide (2014) - Percentage Share Breakdown by Value Sales for In-House Manufacturing, and Outsourced to CMOs..............6

Table 3: Generic Active Pharmaceutical Ingredients Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Avapro Avalide, Benicar HCT, Cozaar Hyzaar, Diovan HCT, and Others.............. 7

Table 4: Pharmaceuticals Services and Active Ingredients (PSAI) Segment Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Europe, India, North America and Rest of the World.............. 8

Table 5: Active Pharmaceutical Ingredient Market for Small Molecules by Category Worldwide (2014) - Percentage Share Breakdown by Value for Generics (Outsourced), In-House, and Patent-Protected (Outsourced)..............9

Table 6: Active Pharmaceutical Ingredients (API) Manufacturers Market by Segment in China (2014) - Percentage Share Breakdown by Value Sales for Biomanufacturing, HPAPI Manufacturing, and Small Molecules API Manufacturing 10 Pharma R&D.............. 11 Table 7: Pharma R&D Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for In-house and Outsourced to Contract Research Organization 11

Table 8: Research & Development Spending in Pharmaceuticals by Category Worldwide (2014) - Percentage Market Share Breakdown by Value for Approval, Discovery, Pre-Clinical, Phase I, Phase II, Phase III, Phase IV, and Others 12 Contract Development and Manufacturing Organisation (CDMO) 13 Table 9: Contract Development and Manufacturing Organisation (CDMO) Market by Region Worldwide (2014) - Percentage Share Breakdown by Value Sales for China, Europe, India, US, and Rest of World.............. 13 Contract Research Organization Services 14 Table 10: Contract Research Organization Services Market by Segment in China (2015) - Percentage Breakdown by Value for Phase I, Phase IIIb-IV, Phase III, Pre-clinical and Other Services.............. 14 Clinical Research Organization (CRO) 15 Table 11: Clinical Research Organization (CRO)'s Revenue by Region Worldwide (2014) - Percentage Market Share Breakdown by Value for US, and Others..............15 Antibiotics.............. 16 Table 12: Infectious Disease Drugs Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Antifungals, Antivirals, Cephalosporins, Macrolides, Penicillins, Quinolones, and Others 16

Table 13: Antibiotics Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Carbapenems, Cephalosporins, Macrolides, Penicillins, Quinolones, and Others.............. 17

Table 14: Antibiotics Market by Category in China (2014) - Percentage Share Breakdown by Value Sales for Carbapenems, Cephalosporins, Macrolides, Penicillins, Quinolones, and Others.............. 18

Table 15: Antibiotic Market by Drug Type in the US (2015) - Percentage Share Breakdown by Podiatrists Prescription for Cephalosporins, Macrolides, Penicillins, Quinolones, and Tetracyclines.............. 19 OTC Drugs.............. 20 Table 16: Over-the-Counter (OTC) Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Private-Label and Others..............20

Table 17: Over-The-Counter (OTC) Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Analgestics, Cough and Cold, Digestive, Eye Care, Skin Care, Vitamins, and Others.............. 21

Table 18: Over-the-Counter (OTC) Market by Category in Australia (2015) - Percentage Share Breakdown by Value for Private-Label and Others..............22

Table 19: Over-the-Counter (OTC) Market by Category in Canada (2015) - Percentage Share Breakdown by Value for Private-Label and Others..............23

Table 20: Over-the-Counter (OTC) Market by Category in Chile (2015) - Percentage Share Breakdown by Value for Private-Label and Others..............24

Table 21: OTC Drugs Market by Channel in China (2014) - Percentage Share Breakdown by Value Sales for Clinics, Community Hospital, General Hospital, Pharmacy, Supermarket, and Others.............. 25

Table 22: OTC Drug Sales by Category in China (2014) - Percentage Market Share Breakdown by Value for Anti-Inflammatory, Cold, Gastrointestinal, Gynecological, Minerals, Tonics, Vitamins, Supplements, and Others 26

Table 23: Over-the-Counter (OTC) Market by Category in Germany (2015) - Percentage Share Breakdown by Value for Private-Label and Others..............27

Table 24: Over-the-Counter (OTC) Market by Category in Israel (2015) - Percentage Share Breakdown by Value for Private-Label and Others..............28

Table 25: Over-the-Counter (OTC) Market by Category in the Netherlands (2015) - Percentage Share Breakdown by Value for Private-Label and Others..............29

Table 26: Over-the-Counter (OTC) Market by Category in United Kingdom (2015) - Percentage Share Breakdown by Value for Private-Label and Others..............30

Table 27: Over-the-Counter (OTC) Market by Category in the US (2015) - Percentage Share Breakdown by Value for Private-Label and Others..............31

Table 28: Over-the-Counter (OTC) Market by Category in the US (2015) - Percentage Share Breakdown by Value for Private-Label and Others..............32

Table 29: Over - The - Counter (OTC) Drugs Market by Category in the US (2015) - Percentage Share Breakdown by Value for Cough, Cold, Allergy & Sinus, Digestives, Pain Relief, Vitamins & Supplements, Weight Loss & Nutritional Meal Replacements and Others..............33 Gelatin.............. 34 Table 30: Gelatin Market by End Use Segment Worldwide (2015) - Percentage Share Breakdown by Value for Food, Pharma Capsules and Others.............. 34 Generic Pharmaceuticals..............35 Table 31: Global IV Generics Drug Market by Value Sales (2014) - Percentage Share Breakdown for Fresenius Kabi AG, Hospira, Inc., Mylan, Inc., Novartis International AG, Teva Pharmaceutical Industries Ltd., and Others 35

Table 32: Generic Pharmaceuticals Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Cardiovascular, Central Nervous System (CNS), Dermatology, Diabetes, Hormonal Drugs, Oncology, Respiratory, Rheumatology, and Others..............36

Table 33: Generics Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Europe, India, North America, Russia and Other CIS and Rest of the World 37 Diagnostics.............. 38 Table 34: Diagnostics Market by Segment Worldwide (2014) - Percentage Share Breakdown by Value Sales for Hospitals, Independent Labs, Physician Office Labs and Others 38

Table 35: Diagnostics Market by Segment Worldwide (2014) - Percentage Share Breakdown by Volume Sales for Hospitals, Independent Labs, Physician Office Labs and Others 39 In Vitro Diagnostics (IVD)..............40 Table 36: In Vitro Diagnostics (IVD) Market by Region Worldwide (2015) - Percentage Breakdown by Value for Europe, Japan, US, and Rest of World..............40

Table 37: In Vitro Diagnostics (IVD) Market by Technology Worldwide (2014) - Percentage Share Breakdown by Value Sales for Analytomic Pathology, Blood Work, Conventional Chemistry, Conventional Microbiology, Flow Cytometry, HBGM, Immunoassay, MDx, and Others.............. 41

Table 38: In Vitro Diagnostics (IVD) Market by Technology Worldwide (2015) - Percentage Share Breakdown by Value for Clinical Biochemistry, Hematology and Flow, Hemostasis, Histology and Cytology, Immunoassays, Microbiology, Molecular, and Others.............. 42

Table 39: In Vitro Diagnostics (IVD) Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for Cancer, Cardiovascular (CV), Infectious Disease, and Others 43

Table 40: In Vitro Diagnostics Market by Segment Worldwide (2014) - Percentage Share Breakdown by Value for Anatomic Pathology, Clinical Chemistry, Diabetes Monitoring, Immunoassay, Molecular Diagnostics, Point of Care, and Others 44

Table 41: In-Vitro Diagnostics (IVD) Manufacturer Market by Technology Type Worldwide (2014) - Percentage Share Breakdown by Value Sales for Analytomic Pathology, Blood Work, Conventional Chemistry, Conventional Microbiology, HBGM (Home Blood Glucose Monitoring), Immunoassay, MDX (Molecular Diagnostics) and Others..............45

Table 42: In Vitro Diagnostics (IVD) Laboratory Market by Segment in France (2014) - Percentage Share Breakdown by Value Sales for Instruments, and Reagents 46

Table 43: In Vitro Diagnostics (IVD) Market by Category in France (2014) - Percentage Share Breakdown by Value Sales for Laboratory in Vitro Diagnostics, and Self-Monitoring of Blood Glucose.............. 47

Table 44: In Vitro Diagnostics (IVD) Market by Region in Europe (2014) - Percentage Share Breakdown by Value Sales for Austria, Belgium, France, Germany, Greece, Italy, Netherlands, Poland, Portugal, Spain, Switzerland, UK, and Rest of Europe.............. 48

5. COMPETITIVE LANDSCAPE.............. 49 Clinical Research Organization (CRO) 49 Table 45: Market Shares of Leading Clinical Research Organization (CRO) Companies Worldwide (2014) - Percentage Breakdown by Value Sales for Charles River Laboratories International, Inc., Covance, Inc., ICON Plc, INC Research, Inventiv Health, Inc., Laboratory Corporation of America Holdings, PAREXEL International, Pharmaceutical Product Development LLC, PRA International, Quest Diagnostics, Inc., Quintiles Transnational Holdings, Inc., Wuxi Pharmatech (Cayman) Inc., and Others..............49 Contract Research Organization (CRO) 50 Table 46: Market Shares of Leading Contract Research Organization (CRO) Clinical Service Providers Worldwide (2015) - Percentage Share Breakdown by Value for Pharmaceutical Product Development LLC, PAREXEL International Corporation, Q-Trials and Others 50

Table 47: Market Shares of Leading Contract Research Organizers in China (2015) - Percentage Breakdown by Value for ShangPharma Corporation, Wuxi Pharmatech (Cayman), Inc. and Others.............. 51 Contract Service Organizations (CSO) 52 Table 48: Market Shares of Leading Contract Service Organizations (CSO) by Value Sales in Australia (2014) - Percentage Breakdown for Australian Pharmaceutical Industries (API), Sigma Pharmaceuticals Limited (SIP), and Symbion Pharmacy Services.............. 52 Generics.............. 53 Table 49: Market Shares of Leading Generic Injectable Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Fresenius SE & Co., Hikma Pharmaceuticals, Hospira, Inc., Luitpold Pharmaceuticals, Inc. and Others 53

Table 50: Market Shares of Leading Generic Lidoderm Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for Actavis Plc, Endo International Plc Authorized Generic, Mylan N.V., and Other Generics 54

Table 51: Market Shares of Leading Generics Manufacturers in Australia (2015) - Percentage Share Breakdown by Value for Apotex, Inc., Aspen Pharmaceutical Holdings Ltd., Mylan, Inc., Sandoz and Others..............55

Table 52: Market Shares of Leading Generics Manufacturers by Value Sales in South Africa (2014) - Percentage Breakdown for Adcock Ingram, Aspen Pharmacare Holdings Limited, Cipla Global Limited, Lupin Limited, Novartis International AG, Sanofi S.A., and Others..............56

Table 53: Market Shares of Leading Generic Percocet Manufacturers in the US (2015) - Percentage Breakdown by Value for Actavis Plc, Mallinckrodt Pharmaceuticals, and Others.............. 57

Table 54: Market Shares of Leading Generic Vicodin Manufacturers in the US (2015) - Percentage Share Breakdown by Value for Actavis Plc, Mallinckrodt Pharmaceuticals, and Others.............. 58

Table 55: Market Shares of Leading Generics Manufacturers in the US (2015) - Percentage Share Breakdown by Volume for Actavis plc, Mylan N.V., Sandoz, Teva Pharmaceutical Industries Ltd. and Others..............59

Table 56: Market Shares of Leading Generics Manufacturers in the US (2015) - Percentage Share Breakdown by Value for Apotex, Inc., Dr. Reddy's Laboratories Ltd. and GlaxoSmithKline.............. 60

Table 57: Market Shares of Leading Non-Branded Generics Manufacturers in the US (2015) - Percentage Share Breakdown by Value for Actavis, Mylan N.V., Teva Pharmaceutical Industries Ltd. and Others..............61

Table 58: Market Shares of Leading Derma Generics Manufacturers in the US (2015) - Percentage Share Breakdown by Value for Actavis Plc, Perrigo Company Plc, Sandoz, Taro Pharmaceutical Industries Ltd. and Others 62 Generic Pharmaceuticals..............63 Table 59: Market Shares of Leading Branded Generic Pharmaceutical Companies in Brazil (2014) - Percentage Breakdown by Value for Cimed Indústria Farmacêutica Ltda, Ems Sigma Pharma Group, Hypermarcas S.A., Pfizer, Inc., Takeda Pharmaceutical Company Limited, União Química Farmacêutica Nacional S.A and Others..............63

Table 60: Market Shares of Leading Generics Pharmaceutical Companies in Brazil (2014) - Percentage Breakdown by Value for Achelois Pharmaceuticals, Inc., Ems Sigma Pharma Group, Eurofarma Laboratórios, Hypermarcas S.A., Pfizer, Inc., Sanofi - Medley Indústria Farmacêutica Ltda and Others 64

Table 61: Market Shares of Leading Generic Pharmaceutical Companies by Value Sales in India (2014) - Percentage Breakdown for Abbott India Ltd., Alkem Laboratories Ltd., Cipla Ltd., GlaxoSmithKline Pharmaceuticals Ltd. (GSK), Lupin Ltd., Mankind Pharma, Pfizer Ltd., Ranbaxy Laboratories Ltd., Sun Pharmaceutical Industries Ltd., Zydus Cadila and Others 65 Generic Drugs.............. 66 Table 62: Market Shares of Leading Generic Anti-Acne Drug Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for Mylan, Perrigo Company, Pfizer, Inc., Sandoz and Others.............. 66

Table 63: Market Shares of Leading Generic Injectable Drug Manufacturers Worldwide (2015) - Percentage Breakdown by Volume for Baxter International, Inc., Fresenius SE & Co. KGaA, Hikma Pharmaceuticals Plc, Hospira, Inc., Novartis AG, Pfizer, Inc., Sagent Pharmaceuticals, Inc., Sanofi S.A., and Others.............. 67

Table 64: Market Shares of Leading Generic Anti-acne Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for Mylan N.V., Perrigo Company plc, Pfizer, Inc., Prasco Laboratories, Rouses Point Pharmaceuticals LLC, Sandoz Inc., Taro Pharmaceutical Industries Ltd., and Private Label 68

Table 65: Market Shares of Leading Generic Injectable Drug Manufacturers in the US (2015) - Percentage Share Breakdown by Value for Baxter International, Inc., Fresenius, Hospira, Inc., Novartis (Sandoz), and Others 69

Table 66: Market Shares of Leading IV Generic Drugs Manufacturers by Value Sales in the US (2014) - Percentage Breakdown for Baxter International, Inc., Fresenius Kabi AG, Hospira, Inc., Novartis International AG, Sun Pharmaceutical Industries Limited and Others..............70 Cough & Cold Medicine..............71 Table 67: Market Shares of Leading Cough & Cold Medicine Manufacturers for OTC Worldwide (2015) - Percentage Share Breakdown by Value for Johnson & Johnson, Procter & Gamble Co., and Others.............. 71

Table 68: Market Shares of Leading Cough & Cold Medicine Manufacturers for OTC in Africa Middle East (2015) - Percentage Share Breakdown by Value for GlaxoSmithKline, Johnson & Johnson and Others..............72

Table 69: Market Shares of Leading Cough & Cold Medicine Manufacturers for OTC in Asia-Pacific (2015) - Percentage Share Breakdown by Value for Johnson & Johnson, Procter & Gamble Co., and Others..............73

Table 70: Market Shares of Leading Cough & Cold Medicine Manufacturers for OTC in Europe (2015) - Percentage Share Breakdown by Value for GlaxoSmithKline, Johnson & Johnson, Procter & Gamble Co., and Others 74

Table 71: Market Shares of Leading Cough & Cold Medicine Manufacturers for OTC in Latin America (2015) - Percentage Share Breakdown by Value for GlaxoSmithKline, Johnson & Johnson, Procter & Gamble Co., and Others 75

Table 72: Market Shares of Leading Cough & Cold Medicine Manufacturers for OTC in North America (2015) - Percentage Share Breakdown by Value for Johnson & Johnson, Procter & Gamble Co., and Others..............76

Table 73: Market Shares of Leading Cough and Cold Remedies Manufacturers for Over-the-Counter (OTC) Sector in the US (2015) - Percentage Breakdown by Value for Johnson & Johnson Private Limited, Merck & Co., Inc., Prestige Brands Holdings, Inc., Reckitt Benckiser Group Plc., Sanofi S.A., Private-Label and Others..............77

Table 74: Market Shares of Leading Cough/Cold Remedy Producers by Value Sales in the US OTC Market (2014) - Percentage Breakdown for Johnson & Johnson, Merck & Co., Inc., Prestige Brands Holdings, Inc., Reckitt Benckiser plc., Sanofi S.A. Private Label, and Others 78 Over the Counter Drugs.............. 79 Table 75: Market Shares of Leading Over the Counter Drugs Manufacturers Worldwide (2015) - Percentage Share Breakdown by Value for GlaxoSmithKline-Novartis International AG, Johnson & Johnson and Others..............79

Table 76: Market Shares of Leading Over the Counter (OTC) Drugs Manufacturers in Brazil (2015) - Percentage Share Breakdown by Value for Abbott Laboratories, GlaxoSmithKline, Johnson & Johnson, Sanofi-Aventis and Others 80

Table 77: Market Shares of Leading Over-The-Counter (OTC) Pharmaceutical Companies Worldwide (2014) - Percentage Breakdown by Value for Achelois Pharmaceuticals, Inc., Boehringer Ingelheim Group, Hypermarcas S.A., Procter & Gamble Pharmaceuticals, Inc., Sanofi - Medley Indústria Farmacêutica Ltda, Takeda Pharmaceutical Company Limited and Others.............. 81

Table 78: Market Shares of Leading Over The Counter (OTC) Drugs Manufacturers in Indonesia (2015) - Percentage Share Breakdown by Value for PT Kalbe Farma and Others 82 In Vitro Diagnostics (IVD)..............83 Table 79: Market Shares of Leading In Vitro Diagnostics (IVD) Laboratory Service Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Quest Diagnostics, Inc. (DGX), Laboratory Corporation of America Holdings (LH), Bio-Reference Laboratories, Inc. (BRLI), Myriad Genetics, Inc. (MYGN), and Others..............83

Table 80: Market Shares of Leading In Vitro Diagnostics (IVD) Equipment Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Abbott Laboratories (ABT), Alere, Inc. (ALR), Bayer AG (BAYN), Becton, Dickinson and Company (BDX), BioMerieux SA (BIM), Bio-Rad Laboratories, Inc. (BIO), Danaher Corporation (DHR), Hologic, Inc. (HOLX), LifeScan, Inc., Ortho-Clinical Diagnostics, Inc., Rogers Corporation (ROG), Siemens AG (SIE), Sysmex Corporation, Thermo Fisher Scientific (TMO), Werfen Group, and Others 84

Table 81: Market Shares of Leading In-Vitro Diagnostics (IVD) Laboratory Service Providers Worldwide (2014) - Percentage Share Breakdown by Value Sales for Bio-Reference Laboratories, Inc., Laboratory Corporation of America Holdings, Myriad Genetics, Inc., Quest Diagnostics, Inc. and Others.............. 85

Table 82: Market Shares of Leading In-Vitro Diagnostics (IVD) Manufacturers Worldwide (2014) - Percentage Breakdown by Value Sales for Abbott Healthcare Pvt. Ltd., Alere, Inc., Danaher Corporation, LifeScan, Inc., Roche Holdings, Inc., System Industrie Electronic GmbH, Thermo Fisher Scientific, Inc., and Others.............. 86

Table 83: Market Shares of Leading In Vitro Diagnostics (IVD) Instrumentation (Mid to High throughput Analyzer) Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Hitachi, Ltd., Invetech, KMC Systems Inc., Stratec Biomedical AG, Tecan Group Ltd., and Others 87

Table 84: Market Shares of Leading In-Vitro Diagnostics (IVD) Manufacturers in China (2015) - Percentage Breakdown by Value Sales for Abbott Healthcare Pvt. Ltd., Mindray Medical International Limited, Roche Holdings, Inc., and Others 88

Table 85: Market Shares of Leading In Vitro Diagnostics (IVDs) Companies in the US (2014) - Percentage Share Breakdown by Value for Abbott Laboratories, BioMérieux, Danaher Corporation, The, F. Hoffmann-La Roche AG, Johnson & Johnson, Siemens AG, and Others..............89

Methodology

Our market research methodology is designed to provide the clients with comprehensive and accurate information on various industries and markets. It includes data collection, primary interviews, macro-economic factor analysis, country-level data analysis etc.

The data is gathered from a wide range of sources, including industry reports, government statistics, and company financials. This data is then analyzed and cross-referenced to ensure its accuracy and reliability. Next, primary interviews are conducted with industry experts and key stakeholders to gather their insights and perspectives on the market. This information is then combined with the data collected to provide a complete picture of the market. Macro-economic factor analysis is also carried out to understand the impact of external factors on the market. Finally, country-level data analysis is performed to understand the market dynamics in specific regions and countries.

Reportlinker's market research methodology is designed to provide clients with a clear understanding of the market, its trends, and its future potential.